Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia

Psychiatric Services

Volumn 58, Issue 6, 2007, Pages 844-847

  Byerly, Matthew J ^a   Thompson, Ann ^b   Carmody, Thomas ^a   Bugno, Rhiannon ^a   Erwin, Thomas ^a   Kashner, Michael ^a   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTRONICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCRIPTION; RESEARCH; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; VALIDITY;

EID: 34250791601     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.6.844     Document Type: Article

References (17)

1. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
2. McClellan TA, Cowan G: Use of antipsychotic and antidepressant drugs by chronically ill patients. American Journal of Psychiatry 126:1771-1773, 1970
3. Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics 21:1074-1090, 1999
4. Diaz E, Levine HB, Sullivan MC, et al: Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. Journal of Psychiatry and Neuroscience 26:325-329, 2001
5. Diaz E, Neuse E, Sullivan MC, et al: Adherence to conventional and atypical antipsychotics after hospital discharge. Journal of Clinical Psychiatry 65:354-360, 2004
6. Byerly M, Fisher R, Whatley K, et al: A comparison of electronic monitoring vs clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research 133:129-133, 2005
7. Byerly MJ, Fisher R, Carmody T, et al: A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry 66:997-1001, 2005
8. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Rev. Washington, DC, American Psychiatric Association, 2000
9. Stroup TS, McEvoy JP, Swartz MS, et al: The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophrenia Bulletin 29:15-31, 2003
10. Miller AL, Hall CS, Crismon ML, et al: TIMA Procedural Manual, Schizophrenia Module, Apr 7, 2005. Available at www.dshs.state.tx.us/mhprograms/ tima.shtm
11. Drake RE, Osher FC, Noordsy DL, et al: Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16:57-67, 1990
12. David A, Buchanan A, Reed A, et al: The assessment of insight in psychosis. British Journal of Psychiatry 161:599-602, 1992
13. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13:261-276, 1987
14. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004
15. Lehman AF, Lieberman JA, Dixon LB, et al: Practice guideline for the treatment of patients with schizophrenia, 2nd ed. American Journal of Psychiatry 161(Feb suppl):1-56, 2004
16. Hayward P, Chan N, Kemp R, et al: Medication self-management: a preliminary report on an intervention to improve medication compliance. Journal of Mental Health 4:511-517, 1995
17. Sellwood W, Tarrier N: Demographic factors associated with extreme non-compliance in schizophrenia. Social Psychiatry and Psychiatric Epidemiology 29:172-177, 1994